Lan-Zhen Wang
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
Papers in
-
- Synthesis and biological activity 16
- Synthesis and Characterization of Heterocyclic Compounds 8
- Click Chemistry and Applications 3
- Oncology 12
- Cancer-related Molecular Pathways 6
- PARP inhibition in cancer therapy 5
- Co-authors
- David R. Newell (18 shared papers)Nicola J. Curtin (14 shared papers)Martin Noble (12 shared papers)Jane Endicott (10 shared papers)Roger J. Griffin (16 shared papers)Suzanne Kyle (4 shared papers)Zdeněk Hostomský (4 shared papers)Huw D. Thomas (8 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Organic & Biomolecular Chemistry (3 papers)Molecular Cancer Therapeutics (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Lan-Zhen Wang
32 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 66
- Oncology 560
- Organic Chemistry 549
- Computational Theory and Mathematics 271
- Genetics 67
- Molecular Biology 373
Countries citing papers authored by Lan-Zhen Wang
This map shows the geographic impact of Lan-Zhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan-Zhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan-Zhen Wang more than expected).
Fields of papers citing papers by Lan-Zhen Wang
This network shows the impact of papers produced by Lan-Zhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan-Zhen Wang. The network helps show where Lan-Zhen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan-Zhen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 263 | |
| 2 | 2004 | 137 | |
| 3 | 2018 | 127 | |
| 4 | 2002 | 124 | |
| 5 | 2004 | 120 | |
| 6 | 2015 | 103 | |
| 7 | 2016 | 103 | |
| 8 | 2006 | 71 | |
| 9 | Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. | 2003 | 67 |
| 10 | 2003 | 66 | |
| 11 | 2016 | 49 | |
| 12 | 2003 | 47 | |
| 13 | 2004 | 42 | |
| 14 | 2012 | 32 | |
| 15 | 2010 | 26 | |
| 16 | 2013 | 22 | |
| 17 | 2004 | 20 | |
| 18 | 2007 | 17 | |
| 19 | 2019 | 17 | |
| 20 | 2021 | 17 |
About Lan-Zhen Wang
Lan-Zhen Wang is a scholar working on Organic Chemistry, Oncology, Molecular Biology, Computational Theory and Mathematics and Pharmaceutical Science, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers), Cancer-related Molecular Pathways (6 papers), PARP inhibition in cancer therapy (5 papers), Click Chemistry and Applications (3 papers), Computational Drug Discovery Methods (3 papers), Cancer therapeutics and mechanisms (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Oncology (560 citations), Organic Chemistry (549 citations), Computational Theory and Mathematics (271 citations), Genetics (67 citations) and Molecular Biology (373 citations). Lan-Zhen Wang has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include David R. Newell, Nicola J. Curtin, Martin Noble, Jane Endicott, Roger J. Griffin, Suzanne Kyle, Zdeněk Hostomský, Huw D. Thomas, Stephen E. Webber and Ian Robert Hardcastle. Their work appears in journals such as Journal of Medicinal Chemistry, Organic & Biomolecular Chemistry, Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry Letters and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.